Genital warts begin with infection by human papillomavirus (HPV), most often types 6 and 11, which enter the skin through tiny breaks during sexual contact and can take weeks to months before any visible growth appears. Once they do show up, they range from small, flesh-colored bumps to larger cauliflower-like clusters, depending on where they form and how moist the skin is. The gap between infection and appearance, the variety of forms they can take, and the conditions they get confused with make genital warts more complicated than most people expect.
How HPV Gets In and What Happens Next
Genital warts are caused by low-risk strains of HPV, a group of viruses that infect the outer layers of skin and mucous membranes. The virus passes from person to person through direct skin-to-skin contact during vaginal, anal, or oral sex. It can also spread through close genital contact without penetration. Condoms reduce the risk but do not eliminate it, because HPV can infect skin that a condom does not cover.
Once HPV reaches the basal layer of the epithelium (the deepest part of the skin’s surface), it hijacks the normal cell-growth machinery. In the upper layers of the skin, infected cells develop a distinctive change: their nuclei become irregular and a clear halo forms around each nucleus, giving the cells a hollowed-out look under a microscope. These altered cells are called koilocytes, and they are the hallmark of active HPV infection. Alongside this, the virus drives thickening of the skin’s base layer and overgrowth of tiny blood vessels, producing the raised, bumpy projections that eventually become a visible wart.1Global Library of Women’s Medicine. Human Papillomavirus Infection and Genital Tract Cancer
The incubation period is highly variable. Some people develop warts within a few weeks of exposure, while others may not see anything for several months or even longer. And many people infected with these same HPV types never develop visible warts at all. The virus can sit in the skin without causing any noticeable changes, a state known as subclinical infection. In fact, on the external genitals, these invisible infections are more common than the obvious warty growths most people picture.1Global Library of Women’s Medicine. Human Papillomavirus Infection and Genital Tract Cancer
Which HPV Types Are Responsible
When researchers type the virus found in genital warts, two strains dominate the picture. A study of over 350 men with genital warts in Shanghai found that about 57% were infected with HPV type 6 and roughly 41% with HPV type 11, with the vast majority carrying only a single strain.2PubMed Central. Characteristics of human papillomaviruses infection in men with genital warts in Shanghai These two types are classified as “low-risk” because they very rarely lead to cancer. That is an important distinction: the HPV strains that cause most genital warts are not the same ones linked to cervical, anal, or throat cancers. Those cancers are driven by high-risk types, particularly HPV 16 and 18. A person can be co-infected with both low-risk and high-risk types at the same time, but the warts themselves are overwhelmingly a product of the low-risk strains.
What Genital Warts Actually Look Like
There is no single appearance. Genital warts fall into at least three distinct forms, and the type you get depends partly on where on the body they grow and how moist or dry the skin is.
- Condylomata acuminata: These are the classic “pointed” warts with a soft, cauliflower-like surface. They tend to appear on moist surfaces such as the inner labia, vaginal opening, or under the foreskin. They can be pink, red, or flesh-colored and often grow in clusters.
- Keratotic warts: These have a thick, rough, horny surface that looks more like a common skin wart you might see on a hand. They usually form on drier skin, such as the outer labia or the penile shaft.
- Smooth papular warts: These are dome-shaped, raised bumps without the ragged cauliflower texture. They also tend to show up on relatively dry skin and can be harder to recognize as warts because they lack the classic shaggy appearance.
All three types were described in a clinical review that categorized anogenital warts by their surface texture and preferred location.3The American Journal of Medicine. Clinical Presentation and Natural Course of Anogenital Warts In practice, a person may have more than one type at once, especially if warts have spread across areas with different skin characteristics. Some warts are tiny, barely a millimeter or two, while others grow into larger masses over weeks or months if left untreated. Color ranges from skin-toned to slightly darker, and some warts have a grayish-white surface.
Conditions That Mimic Genital Warts
One of the more common sources of unnecessary panic is mistaking a normal anatomical feature for warts. Vestibular papillomatosis, for example, consists of small, finger-like projections that line the inner surface of the vulva in many women. These projections are arranged in a regular, symmetric pattern, unlike the irregular, clustered appearance of actual warts. Dermoscopy (a magnified skin examination) can help distinguish the two.4PubMed Central. Importance of Dermoscopy to Diagnose Vulvar Vestibular Papillomatosis vs. Warts In men, pearly penile papules, small dome-shaped bumps that ring the head of the penis, are another normal variant that gets mistaken for warts. They do not grow, spread, or change over time, and they are not caused by HPV.
Other conditions that can look like genital warts include molluscum contagiosum (small, firm bumps with a dimple in the center, caused by a different virus entirely), skin tags, sebaceous cysts, and even lichen planus. Because the visual overlap can be significant, a healthcare provider’s examination is often the most reliable way to sort things out. Self-diagnosis from internet images is particularly unreliable here, given how different the three wart types look from one another and how many non-wart conditions occupy the same visual territory.
How Doctors Confirm the Diagnosis
Most genital warts are diagnosed by visual inspection alone. A trained clinician can usually identify condylomata acuminata on sight, especially the classic cauliflower variety. When the diagnosis is less clear, an acetic acid test (applying dilute vinegar to the skin) is sometimes used. The idea is that HPV-infected skin turns white, making subclinical or hard-to-see lesions more visible.
The acetic acid test works well for raised, hyperplastic warts, where its sensitivity is high. But for flatter lesions or subclinical infections, the test is much less reliable and did not help identify additional infected areas in one study of male patients.5PubMed. The acetowhite test in genital human papillomavirus infection in men: what does it add? False positives are another problem: inflamed skin from other causes can turn white too, leading to overdiagnosis. A separate study found that the positive predictive value of colposcopy with acetic acid reached about 72% when compared against tissue biopsy, but virological methods sometimes told a different story, and inflammatory conditions were the main driver of false-positive results.6PubMed. The acetic acid test in evaluation of subclinical genital papillomavirus infection Biopsy is reserved for cases where the diagnosis is uncertain, the warts do not respond to treatment, or there is a concern about possible precancerous changes.
How the Immune System Deals with the Virus
Your body’s immune response is the main factor determining whether warts appear, persist, or go away on their own. When the immune system mounts an effective response, certain immune cells infiltrate the wart tissue and release inflammatory signals that characterize a strong cellular immune reaction. This process leads to wart regression, sometimes slowly, sometimes over several months.7Skin Health and Disease. Consideration of Underlying Immunodeficiency in Refractory or Recalcitrant Warts: A Review of the Literature People who clear HPV without ever developing symptoms tend to have a robust version of this same immune response to HPV proteins, while those who develop persistent lesions often show a weaker one.
This is why genital warts behave so unpredictably. Some people get a single wart that vanishes within months. Others deal with recurrent crops of warts that keep coming back after treatment. A significant fraction of genital warts do eventually clear without intervention, but the timeline is uncertain, and there is no reliable way to predict who will self-resolve and who will not. That uncertainty is itself a major source of stress for people living with the condition.
When the Immune System Is Compromised
People with weakened immune systems face a distinctly harder road with genital warts. Whether the cause is HIV, organ transplant medications, chemotherapy, or another form of immunosuppression, the pattern is the same: warts tend to be more widespread, more resistant to treatment, more likely to come back after removal, and carry a higher risk of progressing toward precancerous changes.8Journal of Pakistan Association of Dermatologists. Treatment of cutaneous and genital warts in immunocompromised patients For these individuals, regular follow-up with a healthcare provider is especially important, and treatment strategies often need to be more aggressive than in someone with a fully functioning immune system.
The Emotional Weight of a Diagnosis
The psychological impact of genital warts is routinely underestimated, sometimes even by the clinicians who treat them. Studies consistently find that people diagnosed with genital warts report significantly higher levels of depression and anxiety compared to those without the condition.9PubMed Central. Evaluation of Psychopathology and Quality of Life in Patients with Anogenital Wart Compared to Control Group Qualitative research paints a more detailed picture: both men and women describe the disease as negatively affecting their romantic and sexual lives, with the unpredictable timeline and uncertain treatment outcomes compounding the emotional burden.10PubMed Central. The quality of life of patients with genital warts: a qualitative study
One finding that stands out is that people with visible genital warts sometimes report lower quality of life than people with objectively more serious HPV-related conditions, such as biopsy-confirmed cervical abnormalities. The visibility and perceived stigma of external warts seem to weigh more heavily on well-being than the medical severity of the diagnosis would suggest.11PubMed Central. Psychological health and well-being in patients with sexually transmitted infections: A prospective cross-sectional study Distress tends to peak right after diagnosis, then gradually eases, but the initial shock can be intense. If you are in that early window, it is worth knowing that your reaction is normal and well-documented, and that the condition is medically manageable even when it feels overwhelming.
How HPV Vaccination Changed the Picture
The quadrivalent HPV vaccine, which targets types 6, 11, 16, and 18, was designed in part to prevent genital warts. Real-world data shows it has delivered on that promise. In one large study, genital wart incidence among women dropped by about 30% in the years after a vaccination program was introduced, with even steeper declines in populations where vaccine uptake was high. A meta-analysis found that in girls aged 15 to 19, genital warts fell by roughly 61% in countries with vaccination coverage above 50%.12PubMed Central. Impact of HPV vaccination on anogenital warts and respiratory papillomatosis Men benefited too, though the effect was smaller in settings where only women were initially vaccinated. A study in Spain found the quadrivalent vaccine’s effectiveness against genital warts in women who received all three doses was about 77%.13Vaccine. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain
One detail worth noting: the bivalent HPV vaccine, which targets only types 16 and 18 (the high-risk cancer strains), showed no effectiveness against genital warts in that same Spanish study. This makes sense, since the bivalent vaccine does not target types 6 and 11, the strains behind the overwhelming majority of warts. If preventing genital warts specifically is a priority, the vaccine formulation matters. Current HPV vaccines available in most countries (the 9-valent version is now standard in many places) cover types 6 and 11 along with several high-risk types.
Vaccination works best before exposure to the virus, which is why it is recommended in adolescence. But it still provides benefit for people who have not yet been infected with all the covered types, even if they have already been sexually active. It will not clear an existing infection or make current warts disappear, but it can protect against strains a person has not yet encountered.
HPV Transmission to Infants and Children
Although genital warts are primarily a sexually transmitted condition in adults, HPV can also pass from mother to child. This vertical transmission can happen during pregnancy or delivery, and infants may acquire the virus through different routes, including passage through an infected birth canal. Horizontal transmission through non-sexual contact with infected caregivers is another documented pathway.14PubMed Central. Human Papillomavirus Infection during Pregnancy and Childhood: A Comprehensive Review
In children, HPV can cause common skin warts and, in rare but serious cases, a condition called juvenile recurrent respiratory papillomatosis, where wart-like growths develop in the airway. This condition is caused by the same low-risk HPV types (6 and 11) responsible for genital warts in adults and can require repeated surgical procedures to keep the airway clear. The existence of this pathway underscores why maternal HPV vaccination before pregnancy has potential benefits that extend beyond the mother’s own health.
Why Recurrence Is So Common
One of the most frustrating aspects of genital warts is their tendency to come back. Even after successful treatment that removes all visible lesions, the virus can persist in surrounding skin that looks completely normal. There is currently no treatment that reliably eradicates HPV from the body. Treatment removes warts, not the infection. This is why recurrence rates remain stubbornly high across every treatment modality, whether topical creams, cryotherapy, laser treatment, or surgical excision.
Recurrence is more likely in the first few months after treatment, and the risk drops over time as the immune system gradually suppresses the virus. For most people with healthy immune function, the body does eventually gain the upper hand, and recurrences become less frequent. But for immunocompromised individuals, as noted earlier, the cycle can be prolonged and more severe.8Journal of Pakistan Association of Dermatologists. Treatment of cutaneous and genital warts in immunocompromised patients Understanding that recurrence reflects the virus’s persistence in normal-looking skin, rather than treatment failure, can help reframe expectations. The goal of treatment is to remove symptomatic warts and reduce viral load, giving the immune system a better chance to take over.
Subclinical Infection and What It Means for Partners
The fact that most HPV infections of the genitals never produce visible warts creates a real communication problem. A person with no symptoms can still carry and transmit the virus. There is no commercially available blood test for HPV, and testing in men is limited to visual inspection or research-grade methods. In women, HPV testing is typically done through cervical screening, which detects high-risk types rather than the low-risk ones that cause warts.
This means that by the time someone develops visible genital warts, their partner may have already been exposed, possibly weeks or months earlier. It also means the source of infection is often impossible to pin down with certainty. A new wart does not necessarily mean a partner has been unfaithful; it could reflect a long-dormant infection from a previous relationship. The virus’s ability to stay hidden in the skin for extended periods before becoming active makes tracing its origin unreliable, and clinicians generally discourage trying to assign blame based on the timing of a wart’s appearance.
For couples navigating a new diagnosis, the practical reality is that HPV is extraordinarily common. Most sexually active people encounter the virus at some point, and the vast majority clear it without ever knowing they were infected. Genital warts are a visible manifestation of a very widespread virus, not a sign of unusual sexual behavior.